SG11201505089YA - Method of making a mycoplasma vaccine - Google Patents
Method of making a mycoplasma vaccineInfo
- Publication number
- SG11201505089YA SG11201505089YA SG11201505089YA SG11201505089YA SG11201505089YA SG 11201505089Y A SG11201505089Y A SG 11201505089YA SG 11201505089Y A SG11201505089Y A SG 11201505089YA SG 11201505089Y A SG11201505089Y A SG 11201505089YA SG 11201505089Y A SG11201505089Y A SG 11201505089YA
- Authority
- SG
- Singapore
- Prior art keywords
- making
- mycoplasma vaccine
- mycoplasma
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/70—Non-animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261746997P | 2012-12-28 | 2012-12-28 | |
| PCT/US2013/076807 WO2014105672A1 (en) | 2012-12-28 | 2013-12-20 | Method of making a mycoplasma vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201505089YA true SG11201505089YA (en) | 2015-07-30 |
Family
ID=49917778
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201505089YA SG11201505089YA (en) | 2012-12-28 | 2013-12-20 | Method of making a mycoplasma vaccine |
| SG10201708028VA SG10201708028VA (en) | 2012-12-28 | 2013-12-20 | Method of making a mycoplasma vaccine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201708028VA SG10201708028VA (en) | 2012-12-28 | 2013-12-20 | Method of making a mycoplasma vaccine |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US9273281B2 (en) |
| EP (1) | EP2938747B1 (en) |
| JP (2) | JP6122146B2 (en) |
| KR (1) | KR102153275B1 (en) |
| CN (2) | CN104968365B (en) |
| AR (1) | AR094648A1 (en) |
| AU (1) | AU2013370983B2 (en) |
| BR (1) | BR112015012711B1 (en) |
| CA (1) | CA2896298C (en) |
| CL (1) | CL2015001562A1 (en) |
| DK (1) | DK2938747T3 (en) |
| EA (1) | EA032772B1 (en) |
| ES (1) | ES2738100T3 (en) |
| HU (1) | HUE045015T2 (en) |
| MX (1) | MX361273B (en) |
| MY (1) | MY173223A (en) |
| PH (1) | PH12015501333A1 (en) |
| PL (1) | PL2938747T3 (en) |
| PT (1) | PT2938747T (en) |
| SG (2) | SG11201505089YA (en) |
| TW (2) | TWI660736B (en) |
| UA (1) | UA121193C2 (en) |
| WO (1) | WO2014105672A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8546149B2 (en) | 2010-08-27 | 2013-10-01 | Intervet Inc. | Potency test for vaccine formulations |
| CN104968365B (en) * | 2012-12-28 | 2018-04-03 | 勃林格殷格翰动物保健有限公司 | The preparation method of mycoplasma vaccine |
| KR102355614B1 (en) * | 2012-12-28 | 2022-01-27 | 베링거잉겔하임베트메디카게엠베하 | Immunogenic composition comprising mycoplasma antigens |
| CN105441368B (en) * | 2016-01-19 | 2019-01-01 | 福清市默克兽医院 | One plant of Mycoplasma bovis and its application |
| WO2017132578A1 (en) * | 2016-01-29 | 2017-08-03 | Advanced Animal Diagnostics, Inc. | Methods and compositions for detecting mycoplasma exposure |
| WO2018027526A1 (en) * | 2016-08-09 | 2018-02-15 | 财团法人农业科技研究院 | Composition for preventing and treating mycoplasma hyorhinis infection, and method for producing said composition |
| EP3576799A4 (en) * | 2017-02-03 | 2020-12-30 | The Administrators of The Tulane Educational Fund | Ophthalmic compositions for therapeutic and prophylactic uses |
| CN110650989B (en) | 2017-05-24 | 2023-03-31 | 三菱化学株式会社 | Molding material and fiber-reinforced composite material |
| AU2020290984A1 (en) | 2019-06-10 | 2022-01-20 | Elanco Us Inc. | Mycoplasma media formulations |
| CN113201050B (en) * | 2020-08-06 | 2022-07-22 | 青岛诺安百特生物技术有限公司 | Staphylococcus aureus bacteriophage perforin and preparation method and application thereof |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| GB1074920A (en) * | 1965-04-21 | 1967-07-05 | Pfizer & Co C | Growth medium for mycoplasma pneumoniae and vaccine production |
| GB1137306A (en) * | 1966-07-11 | 1968-12-18 | Research Corp | Inoculum for poultry |
| JPS5540568B2 (en) | 1972-10-05 | 1980-10-18 | ||
| US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
| US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| ATE473272T1 (en) * | 2000-03-03 | 2010-07-15 | Chemo Sero Therapeut Res Inst | CELL USABLE IN SERUM-FREE CULTURE, CULTURE SUSPENSION AND METHOD FOR VIRUS PRODUCTION AS A VACCINE USING THE CELL |
| JP3402304B2 (en) * | 2000-03-30 | 2003-05-06 | 株式会社微生物化学研究所 | Method for producing feline chlamydia vaccine |
| MY129765A (en) | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
| US7018638B2 (en) | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
| IL159349A0 (en) | 2001-07-02 | 2004-06-01 | Pfizer Prod Inc | One dose vaccination with mycoplasma hyopneumoniae |
| JP2004537543A (en) | 2001-07-02 | 2004-12-16 | ファイザー・プロダクツ・インク | Mycoplasma hyopneumoniae vaccine and method for reducing mycoplasma bovis in cattle |
| US20030147914A1 (en) | 2001-07-02 | 2003-08-07 | Pfizer Inc. | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| JP2005500845A (en) | 2001-08-28 | 2005-01-13 | ファイザー・プロダクツ・インク | Mycoplasma bovis challenge model, mycoplasma bovis administration method and pneumonia lung lesion induction method |
| TWI238721B (en) * | 2003-06-20 | 2005-09-01 | Animal Technology Inst Taiwan | Swine enzootic vaccine, its producing method and usage |
| CA2595556A1 (en) | 2005-02-09 | 2006-08-17 | Magna International Inc. | Method of manufacturing a semi-structural panel |
| JP4693839B2 (en) * | 2005-03-10 | 2011-06-01 | 共立製薬株式会社 | Cell line that can be cultured without animal-derived components, method for producing the same, virus production method using the same, and vaccine production method |
| WO2007042827A2 (en) * | 2005-10-14 | 2007-04-19 | Ivan Petyaev | Treatment and diagnosis of obligate intracellular pathogens |
| MX2009002741A (en) | 2006-09-15 | 2009-05-11 | Medimmune Llc | Mdck cell lines supporting viral growth to high titers and bioreactor process using the same. |
| US20090068231A1 (en) | 2007-09-11 | 2009-03-12 | Wyeth | Live attenuated mycoplasma strains |
| UY31437A1 (en) | 2007-10-29 | 2009-05-29 | MYCOPLASMA BOVIS VACCINE AND SAME USE METHODS | |
| RU2489164C9 (en) | 2007-11-06 | 2014-01-20 | ВАЙЕТ ЭлЭлСи | Mycoplasma hyopneumoniae AVIRULENT ADJUVANT LIVE VACCINE |
| EP2242511A4 (en) | 2008-01-23 | 2012-10-24 | Boehringer Ingelheim Vetmed | Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions |
| US8444989B1 (en) | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
| JPWO2009142086A1 (en) | 2008-05-23 | 2011-09-29 | 学校法人 久留米大学 | Vaccine composition for mycoplasma infection |
| ES2728949T3 (en) | 2008-06-27 | 2019-10-29 | Zoetis Services Llc | Novel adjuvant compositions |
| EP2362780B1 (en) | 2008-10-31 | 2019-12-25 | Boehringer Ingelheim Animal Health USA Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| EP2453913B1 (en) | 2009-05-19 | 2016-06-22 | Bioproperties Pty Ltd | A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof |
| US20110150770A1 (en) | 2009-12-18 | 2011-06-23 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine |
| US8112663B2 (en) | 2010-03-26 | 2012-02-07 | Lsi Corporation | Method to establish redundancy and fault tolerance better than RAID level 6 without using parity |
| CN102258776B (en) | 2011-07-07 | 2013-07-10 | 普莱柯生物工程股份有限公司 | Combined inactivated vaccine against mycoplasma hyopneumoniae (MHP) and mycoplasma hyorhinis and preparation method thereof |
| UA114504C2 (en) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | PCV, MYCOPLASMA HYOPNEUMONIA AND PRRS COMBINED VACCINE |
| UA114503C2 (en) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | PCV AND MYCOPLASMA HYOPNEUMONIA COMBINED VACCINE |
| US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
| KR102355614B1 (en) * | 2012-12-28 | 2022-01-27 | 베링거잉겔하임베트메디카게엠베하 | Immunogenic composition comprising mycoplasma antigens |
| CN104968365B (en) | 2012-12-28 | 2018-04-03 | 勃林格殷格翰动物保健有限公司 | The preparation method of mycoplasma vaccine |
-
2013
- 2013-12-20 CN CN201380066001.XA patent/CN104968365B/en active Active
- 2013-12-20 SG SG11201505089YA patent/SG11201505089YA/en unknown
- 2013-12-20 EA EA201500701A patent/EA032772B1/en not_active IP Right Cessation
- 2013-12-20 WO PCT/US2013/076807 patent/WO2014105672A1/en active Application Filing
- 2013-12-20 PL PL13817835T patent/PL2938747T3/en unknown
- 2013-12-20 ES ES13817835T patent/ES2738100T3/en active Active
- 2013-12-20 DK DK13817835.5T patent/DK2938747T3/en active
- 2013-12-20 CN CN201810161003.1A patent/CN108379571A/en active Pending
- 2013-12-20 CA CA2896298A patent/CA2896298C/en active Active
- 2013-12-20 SG SG10201708028VA patent/SG10201708028VA/en unknown
- 2013-12-20 EP EP13817835.5A patent/EP2938747B1/en active Active
- 2013-12-20 MX MX2015007730A patent/MX361273B/en active IP Right Grant
- 2013-12-20 US US14/135,796 patent/US9273281B2/en active Active
- 2013-12-20 MY MYPI2015001621A patent/MY173223A/en unknown
- 2013-12-20 BR BR112015012711-8A patent/BR112015012711B1/en active IP Right Grant
- 2013-12-20 JP JP2015549759A patent/JP6122146B2/en active Active
- 2013-12-20 HU HUE13817835 patent/HUE045015T2/en unknown
- 2013-12-20 KR KR1020157020447A patent/KR102153275B1/en active IP Right Grant
- 2013-12-20 PT PT13817835T patent/PT2938747T/en unknown
- 2013-12-20 UA UAA201507463A patent/UA121193C2/en unknown
- 2013-12-20 AU AU2013370983A patent/AU2013370983B2/en not_active Ceased
- 2013-12-27 TW TW107103700A patent/TWI660736B/en active
- 2013-12-27 TW TW102148875A patent/TWI618542B/en active
- 2013-12-27 AR ARP130105050A patent/AR094648A1/en unknown
-
2015
- 2015-06-05 CL CL2015001562A patent/CL2015001562A1/en unknown
- 2015-06-15 PH PH12015501333A patent/PH12015501333A1/en unknown
-
2016
- 2016-01-19 US US15/000,342 patent/US10512680B2/en active Active
-
2017
- 2017-03-30 JP JP2017067820A patent/JP6449364B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1207967A1 (en) | Vaccine | |
| SG10201708028VA (en) | Method of making a mycoplasma vaccine | |
| GB2501243B (en) | Method of making a medical balloon | |
| EP2913831A4 (en) | Rare-earth-magnet production method | |
| EP2939754A4 (en) | Draw forming method | |
| EP2876161A4 (en) | Vaccine | |
| GB201223386D0 (en) | Vaccine | |
| IL234024A0 (en) | Method of making a multilayr article | |
| GB2517862B (en) | Method of marking a line | |
| PL2931937T3 (en) | Method of producing metal-nanoparticle-arrays | |
| SG11201504454RA (en) | A method of vitrification | |
| PL2809816T3 (en) | Expression method | |
| EP2824130A4 (en) | Method for producing polydialkylsilane | |
| GB201220155D0 (en) | Method of manufacture | |
| LU92341B1 (en) | Method of producing a shaped component | |
| SG2013017017A (en) | A method of separation | |
| HRP20181348T1 (en) | Method of making a panel | |
| SG2013085071A (en) | Method of producing methionine | |
| PL2662656T3 (en) | Method of construction of a radiator | |
| EP2832696A4 (en) | Mayenite production method | |
| GB201215942D0 (en) | Method of treatent | |
| HK1208864A1 (en) | A preparation method of ecteinascidin-743 intermediate -743 | |
| GB201215939D0 (en) | Method of preparing monomers | |
| EP2812301A4 (en) | Method of producing alcohols | |
| GB201202090D0 (en) | Vaccine |